title: Disruption of growth hormone receptor prevents calorie restriction from improving insulin action and longevity.
abstract: Most mutations that delay aging and prolong lifespan in the mouse are related to somatotropic and/or insulin signaling. Calorie restriction (CR) is the only intervention that reliably increases mouse longevity. There is considerable phenotypic overlap between long-lived mutant mice and normal mice on chronic CR. Therefore, we investigated the interactive effects of CR and targeted disruption or knock out of the growth hormone receptor (GHRKO) in mice on longevity and the insulin signaling cascade. Every other day feeding corresponds to a mild (i.e. 15%) CR which increased median lifespan in normal mice but not in GHRKO mice corroborating our previous findings on the effects of moderate (30%) CR on the longevity of these animals. To determine why insulin sensitivity improves in normal but not GHRKO mice in response to 30% CR, we conducted insulin stimulation experiments after one year of CR. In normal mice, CR increased the insulin stimulated activation of the insulin signaling cascade (IR/IRS/PI3K/AKT) in liver and muscle. Livers of GHRKO mice responded to insulin by increased activation of the early steps of insulin signaling, which was dissipated by altered PI3K subunit abundance which putatively inhibited AKT activation. In the muscle of GHRKO mice, there was elevated downstream activation of the insulin signaling cascade (IRS/PI3K/AKT) in the absence of elevated IR activation. Further, we found a major reduction of inhibitory Ser phosphorylation of IRS-1 seen exclusively in GHRKO muscle which may underpin their elevated insulin sensitivity. Chronic CR failed to further modify the alterations in insulin signaling in GHRKO mice as compared to normal mice, likely explaining or contributing to the absence of CR effects on insulin sensitivity and longevity in these long-lived mice.
authors.affiliation: Department of Internal Medicine, Geriatrics Research, Southern Illinois University School of Medicine, Springfield, Illinois, United States of America.
authors.forename: Michael S
authors.initials: MS
authors.lastname: Bonkowski
authors.forename: Fernando P
authors.initials: FP
authors.lastname: Dominici
authors.forename: Oge
authors.initials: O
authors.lastname: Arum
authors.forename: Juliana S
authors.initials: JS
authors.lastname: Rocha
authors.forename: Khalid A
authors.initials: KA
authors.lastname: Al Regaiey
authors.forename: Reyhan
authors.initials: R
authors.lastname: Westbrook
authors.forename: Adam
authors.initials: A
authors.lastname: Spong
authors.forename: Jacob
authors.initials: J
authors.lastname: Panici
authors.forename: Michal M
authors.initials: MM
authors.lastname: Masternak
authors.forename: John J
authors.initials: JJ
authors.lastname: Kopchick
authors.forename: Andrzej
authors.initials: A
authors.lastname: Bartke
mesh_terms: D000818:Animals; D031204:Caloric Restriction; D007328:Insulin / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D008136:Longevity; D051379:Mice; D018345:Mice, Knockout; D009132:Muscles / Q000378:metabolism; D011986:Receptors, Somatotropin / Q000235:genetics / Q000502:physiology*; D015398:Signal Transduction
chemical_list: D007328:Insulin; D011986:Receptors, Somatotropin